ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,583,038 | +3.3% | 348,787 | -0.9% | 0.01% | 0.0% |
| Q2 2023 | $4,436,371 | +97639.0% | 352,093 | +1.2% | 0.01% | -16.7% |
| Q1 2023 | $4,539 | -24.9% | 347,834 | +1.5% | 0.01% | -25.0% |
| Q4 2022 | $6,045 | -99.9% | 342,715 | -2.5% | 0.01% | 0.0% |
| Q3 2022 | $5,353,000 | +4.0% | 351,456 | +1.3% | 0.01% | 0.0% |
| Q2 2022 | $5,147,000 | -34.5% | 347,087 | -0.5% | 0.01% | -20.0% |
| Q1 2022 | $7,859,000 | +16.1% | 348,977 | -4.9% | 0.01% | +25.0% |
| Q4 2021 | $6,771,000 | +38.0% | 367,015 | -0.0% | 0.01% | +14.3% |
| Q3 2021 | $4,907,000 | -41.6% | 367,049 | -19.2% | 0.01% | -36.4% |
| Q2 2021 | $8,409,000 | +14.0% | 454,284 | -7.5% | 0.01% | +10.0% |
| Q1 2021 | $7,375,000 | -2.4% | 491,159 | -6.2% | 0.01% | 0.0% |
| Q4 2020 | $7,558,000 | +76.8% | 523,408 | -0.4% | 0.01% | +42.9% |
| Q3 2020 | $4,276,000 | +12.8% | 525,313 | -6.2% | 0.01% | +16.7% |
| Q2 2020 | $3,791,000 | -4.0% | 559,967 | -0.2% | 0.01% | -25.0% |
| Q1 2020 | $3,951,000 | -25.9% | 561,196 | +3.4% | 0.01% | -11.1% |
| Q4 2019 | $5,329,000 | -10.4% | 542,954 | +0.3% | 0.01% | -18.2% |
| Q3 2019 | $5,945,000 | -2.4% | 541,483 | +3.4% | 0.01% | 0.0% |
| Q2 2019 | $6,089,000 | +19.2% | 523,558 | -2.2% | 0.01% | +10.0% |
| Q1 2019 | $5,107,000 | -0.5% | 535,370 | +0.6% | 0.01% | -9.1% |
| Q4 2018 | $5,131,000 | +6.2% | 532,258 | +57.0% | 0.01% | +22.2% |
| Q3 2018 | $4,831,000 | +17.5% | 339,012 | -1.1% | 0.01% | +12.5% |
| Q2 2018 | $4,113,000 | -5.3% | 342,754 | -2.6% | 0.01% | -11.1% |
| Q1 2018 | $4,345,000 | -19.9% | 351,783 | -5.6% | 0.01% | -18.2% |
| Q4 2017 | $5,424,000 | +0.0% | 372,806 | -2.2% | 0.01% | -8.3% |
| Q3 2017 | $5,423,000 | +11.7% | 381,113 | +0.2% | 0.01% | +9.1% |
| Q2 2017 | $4,855,000 | +13.8% | 380,476 | +13.1% | 0.01% | +10.0% |
| Q1 2017 | $4,265,000 | +29.6% | 336,347 | +4.4% | 0.01% | +25.0% |
| Q4 2016 | $3,291,000 | -16.7% | 322,320 | +7.5% | 0.01% | -27.3% |
| Q3 2016 | $3,949,000 | +8.7% | 299,852 | +4.8% | 0.01% | 0.0% |
| Q2 2016 | $3,633,000 | -2.6% | 286,036 | +1.3% | 0.01% | -8.3% |
| Q1 2016 | $3,731,000 | -11.7% | 282,451 | +2.9% | 0.01% | -14.3% |
| Q4 2015 | $4,224,000 | +24.3% | 274,621 | +0.2% | 0.01% | +16.7% |
| Q3 2015 | $3,398,000 | -0.1% | 274,041 | +10.3% | 0.01% | +9.1% |
| Q2 2015 | $3,400,000 | +16.9% | 248,563 | +2.2% | 0.01% | +37.5% |
| Q1 2015 | $2,908,000 | -1.2% | 243,149 | +5.5% | 0.01% | -11.1% |
| Q4 2014 | $2,942,000 | -3.0% | 230,409 | +1.9% | 0.01% | 0.0% |
| Q3 2014 | $3,033,000 | -13.8% | 226,064 | +3.1% | 0.01% | -10.0% |
| Q2 2014 | $3,518,000 | -14.1% | 219,167 | -3.5% | 0.01% | -16.7% |
| Q1 2014 | $4,094,000 | +14.9% | 227,081 | -1.4% | 0.01% | +9.1% |
| Q4 2013 | $3,562,000 | -5.3% | 230,371 | -8.9% | 0.01% | -8.3% |
| Q3 2013 | $3,761,000 | +9.1% | 252,917 | -5.1% | 0.01% | +9.1% |
| Q2 2013 | $3,447,000 | – | 266,383 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |